DIACCURATE
DIACCURATE
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.diaccurate.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
AntiGrade
AntiGrade is a biotechnology company.
Hepatera
Hepatera is a biotechnology company.
Kyowa Hakko Europe
Kyowa Hakko Europe is a biotechnology company.
UVera
UVera is a biotechnology company.
Current Employees Featured
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-08 | Diaccurate Appoints Laurence Riot Lamotte as Chief Financial Officer |
Official Site Inspections
http://www.diaccurate.com
- Host name: diaccurate.com
- IP address: 141.95.222.70
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Diaccurate"
Diaccurate - Crunchbase Company Profile & Funding
Diaccurate is a biotechnology company that treats endocrine-resistant metastatic breast tumors, glioblastoma, and refractory acute myeloid leukemia. To beat incurable cancers, Diaccurate …See details»
Diaccurate SA - Drug pipelines, Patents, Clinical trials - Synapse
Diaccurate SASU is a biopharmaceutical company that specializes in the research and development of diagnostic products, particularly in the field of theranostics. ... The statistics for …See details»
Innovative clinical-stage biotech company - Evextabio
Evexta Bio, formerly Diaccurate, is a biopharmaceutical company exploring the new frontiers of oncology in search of daring novel therapeutic approaches with the potential to save lives. …See details»
DIACCURATE Overview | SignalHire Company Profile
DIACCURATE is a private company that has been in the industry for 9 years. The company currently specializes in the Biotechnology area. ... Organization Website: diaccurate.com : …See details»
Diaccurate - Products, Competitors, Financials, Employees, …
Diaccurate is a biotechnology company specializing in the development of ontology therapies. It develops therapies for the treatment of human immunodeficiency virus infection and diseases …See details»
Diaccurate - Updates, News, Events, Signals & Triggers - Crunchbase
BioSpace — Diaccurate Announces the Appointment of Scott Filosi as CEO and Corporate Name Change to Evexta Bio News • Jan 5, 2023 Globe Newswire — Diaccurate receives support …See details»
DIACCURATE Company Profile - Office Locations, Competitors
DIACCURATE is a company specializing in the immunotherapy. It develops an enzymatic mechanism involved in the control of immune responses against HIV and other pathogens. …See details»
Diaccurate - Crunchbase
Diaccurate, Ceres Biotics, o2h group, UVera, Postbiotica, and AntiGrade are all part of the biotechnology industry. Ceres Biotics, o2h group, UVera, Postbiotica, and AntiGrade are …See details»
DIACCURATE Company Profile | PARIS, ILE DE FRANCE, France
Find company research, competitor information, contact details & financial data for DIACCURATE of PARIS, ILE DE FRANCE. Get the latest business insights from Dun & Bradstreet.See details»
Diaccurate Announces the Appointment of Scott Filosi as CEO and ...
Nov 6, 2023 Scott Filosi brings more than 30 years of experience in market access and commercialization of innovative medicines at a global level. New name reflects the company's …See details»
diaccurate.com - Homepage | Diaccurate - Diaccurate - Sur.ly
Diaccurate.com. Spin-off from the Pasteur Institute, DIACCURATE is a late preclinical stage biotechnology company which develops “sole-in-class” t...See details»
Diaccurate - Funding, Financials, Valuation & Investors - Crunchbase
Jan 5, 2022 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 5, 2022: …See details»
Diaccurate · 104 Boulevard De Sebastopol, Paris, 75003, FRA
DIACCURATE is an entity in Paris, registered with the System for Award Management (SAM) of U.S. General Services Administration (GSA). The entity was registered on April 14, 2022 with …See details»
Diaccurate S.A.. (9/8/21). "Press Release: Diaccurate Acquires …
“Diaccurate is laying the foundations of a successful modern biotech company with a new highly specialized portfolio approach. This is an exciting agreement that will take the Company to the …See details»
Homepage | Evextabio
Oct 25, 2024 Diaccurate Appoints Scott Filosi as CEO. Our Oral Optimized S6 Kinase Inhibitor Is Now Rupitasertib. Our Selective KIF20A Inhibitor is now EVX-020 . Latest news. Evexta Bio …See details»
DIACC-2010 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 Contacts Dominique Bridon, CEO +33 (0)1 78 95 80 17 [email protected] ATCG PARTNERS Marie Puvieux +33 (0)9 52 78 85 08 [email protected] 1 A …See details»
Diaccurate - Contacts, Employees, Board Members, Advisors
Organization. Diaccurate . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. Diaccurate has 3 …See details»
DIACCURATE acquires BIOKINESIS to create a sole-in-class biotech …
Jan 12, 2021 DIACCURATE is conducting 3 proprietary development programs of highy innovative drug-candidates: the KIF20A inhibitor DIACC2010 disrupts intracellular trafficking to …See details»
Diaccurate - Tech Stack, Apps, Patents & Trademarks - Crunchbase
The intellectual property of Diaccurate includes 23 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, Diaccurate has …See details»
DIACCURATE ACQUIRES BIOKINESIS TO CREATE A SOLE-IN
Jan 12, 2021 o DIACCURATE is now developing 3 programs in cancer and immunotherapy o DIACCURATE will be initiating a first clinical trial by early 2022 . Paris, France, January 12, …See details»